Bruce Power and its network of supplier partners have announced a $100,000 donation to the Pediatric Oncology Group of Ontario (POGO) to assist young patients and their families as they navigate cancer diagnosis and treatment.
The financial contribution will aid POGO in delivering specialized services to children undergoing treatment, survivors, and their loved ones across the province.
“Bruce Power and our supplier partners believe strongly in the high-quality wrap-around care and supports POGO has developed over the years to serve its young patients and families,” said Pat Dalzell, Vice-President of Corporate Affairs, Market Development and Operational Services at Bruce Power. “By supporting POGO, families can be assured they will receive the best emotional, practical and financial support throughout their cancer care.”
The annual collaboration between the nuclear operator and its business partners helps maintain stable funding for essential provincial programs.
“We are thrilled at the consistent and unyielding support Bruce Power and its supplier partners provide to Pediatric Oncology Group of Ontario year after year,” said Lauren Ettin, Chief Executive Officer of POGO. “This ongoing generosity helps us strengthen and confidently deliver vital programs to support children and youth with cancer, survivors and their families with the best possible care.”
Alongside its charitable contributions, Bruce Power plays a major role in global cancer treatment by producing medical isotopes. The company's reactors harvest Cobalt-60, which sterilizes 40 per cent of the world's medical devices and helps treat breast cancer and brain tumours.
Additionally, Bruce Power expanded its facilities in 2022 and 2024 by installing two Isotope Production Systems to produce lutetium-177, a medical isotope used to treat prostate cancer and neuroendocrine tumours. A third production system is scheduled for installation in Unit 6 in 2027 to boost supply redundancy and keep pace with emerging medical research.
